Skip to main content
NIH funding notice RFA-MH-25-160

Suicide Prevention Across the Life Span in Low- and Middle-Income Countries (R34 Clinical Trial Optional)

Closed on October 24, 2024.

Posted
June 3, 2024
Close date
October 24, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $664,921 in first-year total cost, median $664,921.

Most frequent study sections

  1. Special Emphasis Panel[ZMH1 ERB-N (03)]1

Most frequent institutions

  1. UNIVERSITY OF BOTSWANA1
Competing awards under RFA-MH-25-160 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Adaptation and Implementation of Safety Planning for Suicide Prevention Among Youth in Botswana1R34MH136019-01A1MBAKILE-MAHLANZA, LINGANIVAN PELT, AMELIA ELIZABETHUNIVERSITY OF BOTSWANA$664,921ZMH1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-MH-25-160: Suicide Prevention Across the Life Span in Low- and Middle-Income Countries (R34 Clinical Trial Optional) | ScienceDex | ConductScience